Neurimmune

AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
Biopharma Reporter
Tue, 03/1/22 - 10:23 am
Alexion
AstraZeneca
Neurimmune
N!006
monoclonal antibodies
transthyretin amyloid cardiomyopathy
AstraZeneca and Neurimmune to develop investigational human monoclonal antibody NI006
Biopharma Reporter
Mon, 01/10/22 - 11:43 am
Alexion
AstraZeneca
Neurimmune
NI006
ATTR-CM
AstraZeneca goes bigger in amyloidosis with Neurimmune deal
Pharmaforum
Fri, 01/7/22 - 10:33 am
AstraZeneca
ATTR
Neurimmune
NI006
Biogen Pays $50 million to Reduce Future Royalty Payments on Alzheimer’s Drug Aducanumab
CP Wire
Tue, 05/1/18 - 09:48 am
Biogen
Alzheimer's disease
aducanumab
Neurimmune